CCT6A, a novel prognostic biomarker for Ewing sarcoma

BACKGROUND: Ewing sarcoma (ES), the second most prevalent bone malignant tumor has no widely known prognostic biomarker. Earlier studies have suggested that chaperonin containing TCP1 complex 6A (CCT6A), which encodes a molecular protein chaperone, is involved in the pathogenesis of many cancers. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jie, Liu, Chong, Xu, Guoyong, Liang, Tuo, Yu, Chaojie, Liao, Shian, Zhang, Zide, Lu, Zhaojun, Wang, Zequn, Chen, Jiarui, Chen, Tianyou, Li, Hao, Zhan, Xinli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850773/
https://www.ncbi.nlm.nih.gov/pubmed/33530265
http://dx.doi.org/10.1097/MD.0000000000024484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850773/
https://www.ncbi.nlm.nih.gov/pubmed/33530265
http://dx.doi.org/10.1097/MD.0000000000024484

Ejemplares similares